Generic drug
Flecainide price, strengths & recalls
Pharmacies pay $3.22 for 30 tablets of Flecainide 50 mg tablet this week, and from $3.22 to $8.42 across its 3 priced strengths and forms. 13 manufacturers make it. It has 2 recalls on record, none ongoing. Its official label last changed on December 6, 2024.
Generic- Fair cash price
- $14.20
- Strengths
- 3
- Makers
- 13
- Updated
- Nov 11
Flecainide price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 50 mg tablet | $0.1074 | $3.22 / 30 tablets |
| 100 mg tablet | $0.1739 | $5.22 / 30 tablets |
| 150 mg tablet | $0.2808 | $8.42 / 30 tablets |
The lowest cost per tablet is 50 mg tablet at $0.1074. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Flecainide
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
Flecainide Acetate Tablets, USP
Mortality
Flecainide acetate was included in the National Heart Lung and Blood Institute's Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multicenter, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had a myocardial infarction more than six days but less than two years previously. An excessive mortality or non-fatal cardiac arrest rate was seen in patients treated with flecainide acetate compared with that seen in patients assigned to a carefully matched placebo-treated group. This rate was 16/315 (5.1%) for flecainide acetate and 7/309 (2.3%) for the matched placebo. The average duration of treatment with flecainide acetate in this study was ten months.
The applicability of the CAST results to other populations (e.g., those without recent myocardial infarction) is uncertain, but at present, it is prudent to consider the risks of Class IC agents (including flecainide acetate), coupled with the lack of any evidence of improved survival, generally unacceptable in patients without life-threatening ventricular arrhythmias, even if the patients are experiencing unpleasant, but not life-threatening, symptoms or signs.
Ventricular Pro-arrhythmic Effects in Patients with Atrial Fibrillation/Flutter
A review of the world literature revealed reports of 568 patients treated with oral flecainide acetate for paroxysmal atrial fibrillation/flutter (PAF). Ventricular tachycardia was experienced in 0.4% (2/568) of these patients. Of 19 patients in the literature with chronic atrial fibrillation (CAF), 10.5% (2) experienced VT or VF. FLECAINIDE IS NOT RECOMMENDED FOR USE IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION. Case reports of ventricular proarrhythmic effects in patients treated with flecainide for atrial fibrillation/flutter have included increased PVCs, VT, ventricular fibrillation (VF), and death.
As with other Class I agents, patients treated with flecainide acetate for atrial flutter have been reported with 1:1 atrioventricular conduction due to slowing the atrial rate. A paradoxical increase in the ventricular rate also may occur in patients with atrial fibrillation who receive flecainide acetate. Concomitant negative chronotropic therapy such as digoxin or beta-blockers may lower the risk of this complication.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Generic makers
- 7 approved generic applications on the market
Flecainide questions
How much does flecainide cost without insurance?
Pharmacies pay about $3.22 for 30 tablets of flecainide 50 mg tablet ($0.1074 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $14.20. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
Is flecainide in shortage?
No shortage is reported for flecainide right now. We check the national shortage list every day.
Has flecainide been recalled?
2 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the flecainide label last change?
The official label was last updated on December 6, 2024 (version 11). See what changed.
Talk about flecainide
No comments yet. Questions, tips, what worked for you - start the conversation.